UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000021499
Receipt No. R000024795
Official scientific title of the study Research for cryopreservation and reuse of ovarian tissue and oocytes using ovaries obtained from gender identity disorder patients
Date of disclosure of the study information 2016/03/16
Last modified on 2018/03/19 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Research for cryopreservation and reuse of ovarian tissue and oocytes using ovaries obtained from gender identity disorder patients
Title of the study (Brief title) Research for cryopreservation and reuse of ovarian tissue and oocytes using ovaries obtained from gender identity disorder patients
Region
Japan North America

Condition
Condition gender identity disorder
Classification by specialty
Obsterics and gynecology Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Establishment of cryopreservation and reuse of ovarian tissue and oocytes and its application to infertility and fertility preservation of cancer patients
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes viability of transplanted ovarian tissue
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
45 years-old >=
Gender Female
Key inclusion criteria Gender identity disorder patients who undergo sex reassignment surgery (hysterectomy and oophorectomy) and provide informed consent to the present research
Key exclusion criteria Gender identity disorder patients who do not provide informed consent to the research or for whom sex reassignment surgery is contraindicated
Target sample size 100

Research contact person
Name of lead principal investigator Yasushi Takai
Organization Saitama Medical Center/ Saitama Medical University
Division name Department of Obstetrics and Gynecology
Address 1981 Kamoda, Kawagoe, Saitama, Japan
TEL 049-228-3681
Email yastakai@saitama-med.ac.jp

Public contact
Name of contact person Yasushi Takai
Organization Saitama Medical Center/ Saitama Medical University
Division name Department of Obstetrics and Gynecology
Address 1981 Kamoda, Kawagoe, Saitama, Japan
TEL 049-228-3681
Homepage URL
Email yastakai@saitama-med.ac.jp

Sponsor
Institute Saitama Medical University
Institute
Department

Funding Source
Organization Grants-in-Aid for Scientific Research
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 03 Month 16 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2011 Year 05 Month 01 Day
Anticipated trial start date
2011 Year 05 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Cohort study for GID patients who visit our clinic between May 1, 2011 and March 31, 2016 and are eligible for our study protocol.
Ovarian tissue and oocytes obtained by sex reassignment surgery are cryopreserved. Cryopreserved ovarian tissue are thawed and transplanted to immunodeficient mice, and survival rate of oocytes is evaluated.
Oogonial stem cells are extracted from cryopreserved ovarian tissue, and utilized for oocyte survival in the transplanted tissue.

Management information
Registered date
2016 Year 03 Month 16 Day
Last modified on
2018 Year 03 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024795